These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 29311381)

  • 1. Metabolic Barriers to T Cell Function in Tumors.
    Sugiura A; Rathmell JC
    J Immunol; 2018 Jan; 200(2):400-407. PubMed ID: 29311381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.
    Rivadeneira DB; Delgoffe GM
    Clin Cancer Res; 2018 Jun; 24(11):2473-2481. PubMed ID: 29386217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in cancer; can they be controlled?
    Adeegbe DO; Nishikawa H
    Immunotherapy; 2015; 7(8):843-6. PubMed ID: 26316166
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic reprograming of anti-tumor immunity.
    Sukumar M; Kishton RJ; Restifo NP
    Curr Opin Immunol; 2017 Jun; 46():14-22. PubMed ID: 28412583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell immunometabolism against cancer.
    Jiang S; Yan W
    Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
    Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
    Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Tissue Resident Memory T Cells.
    Mami-Chouaib F; Tartour E
    Front Immunol; 2019; 10():1018. PubMed ID: 31191515
    [No Abstract]   [Full Text] [Related]  

  • 8. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.
    Lim AR; Rathmell WK; Rathmell JC
    Elife; 2020 May; 9():. PubMed ID: 32367803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
    Rangel Rivera GO; Knochelmann HM; Dwyer CJ; Smith AS; Wyatt MM; Rivera-Reyes AM; Thaxton JE; Paulos CM
    Front Immunol; 2021; 12():645242. PubMed ID: 33815400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-resident memory-like T cells in tumor immunity: Clinical implications.
    Dhodapkar MV; Dhodapkar KM
    Semin Immunol; 2020 Jun; 49():101415. PubMed ID: 33011063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting T cell metabolism for immunotherapy.
    Gao J; Liu Y; Wei J; Jiang L; Mao J; Chang CH; Wu D
    J Leukoc Biol; 2021 Dec; 110(6):1081-1090. PubMed ID: 34779530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional T cell metabolism in the tumor microenvironment.
    Beckermann KE; Dudzinski SO; Rathmell JC
    Cytokine Growth Factor Rev; 2017 Jun; 35():7-14. PubMed ID: 28456467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches.
    Klein K; He K; Younes AI; Barsoumian HB; Chen D; Ozgen T; Mosaffa S; Patel RR; Gu M; Novaes J; Narayanan A; Cortez MA; Welsh JW
    Front Immunol; 2020; 11():573326. PubMed ID: 33178201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathways: hypoxia response in immune cells fighting or promoting cancer.
    Palazón A; Aragonés J; Morales-Kastresana A; de Landázuri MO; Melero I
    Clin Cancer Res; 2012 Mar; 18(5):1207-13. PubMed ID: 22205687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
    Li X; Xiang Y; Li F; Yin C; Li B; Ke X
    Front Immunol; 2019; 10():2293. PubMed ID: 31616443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.
    Allison KE; Coomber BL; Bridle BW
    Immunology; 2017 Oct; 152(2):175-184. PubMed ID: 28621843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic Competition in Tumor Microenvironment].
    Eikawa S; Udono H
    Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruiting T cells in cancer immunotherapy.
    Yost KE; Chang HY; Satpathy AT
    Science; 2021 Apr; 372(6538):130-131. PubMed ID: 33833111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.